These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8509145)

  • 1. Murine complement receptor gene expression: Cr2 gene transcripts are depressed during a high dose microbial challenge.
    Tan SS; O'Toole EM; Kurtz CB; Weis JH
    Immunology; 1993 May; 79(1):82-8. PubMed ID: 8509145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene.
    Christensen SM; Martin BK; Tan SS; Weis JH
    J Immunol; 1992 Jun; 148(11):3610-7. PubMed ID: 1534100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products.
    Martin BK; Weis JH
    Eur J Immunol; 1993 Nov; 23(11):3037-42. PubMed ID: 7693486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations.
    Holguin MH; Kurtz CB; Parker CJ; Weis JJ; Weis JH
    J Immunol; 1990 Sep; 145(6):1776-81. PubMed ID: 2144008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry.
    Kurtz CB; Paul MS; Aegerter M; Weis JJ; Weis JH
    J Immunol; 1989 Sep; 143(6):2058-67. PubMed ID: 2528587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1.
    Kurtz CB; O'Toole E; Christensen SM; Weis JH
    J Immunol; 1990 May; 144(9):3581-91. PubMed ID: 2139460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1.
    Quigg RJ; Holers VM
    J Immunol; 1995 Aug; 155(3):1481-8. PubMed ID: 7636211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins.
    Rayhel EJ; Dehoff MH; Holers VM
    J Immunol; 1991 Mar; 146(6):2021-6. PubMed ID: 1706386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21), and co-signaling molecule CD19 in cattle.
    Pringle ES; Firth MA; Chattha KS; Hodgins DC; Shewen PE
    Dev Comp Immunol; 2012 Dec; 38(4):487-94. PubMed ID: 22989997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21).
    Fingeroth JD
    J Immunol; 1990 May; 144(9):3458-67. PubMed ID: 2139457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.
    Makar KW; Pham CT; Dehoff MH; O'Connor SM; Jacobi SM; Holers VM
    J Immunol; 1998 Feb; 160(3):1268-78. PubMed ID: 9570543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of complement receptors 1 and 2 on mouse splenic B cells using flow cytometry.
    Donius LR; Weis JH
    Methods Mol Biol; 2014; 1100():305-10. PubMed ID: 24218269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
    Hedrick JA; Watry D; Speiser C; O'Donnell P; Lambris JD; Tsoukas CD
    Eur J Immunol; 1992 May; 22(5):1123-31. PubMed ID: 1315687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
    June RA; Landay AL; Stefanik K; Lint TF; Spear GT
    Immunology; 1992 Jan; 75(1):59-65. PubMed ID: 1371493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 5'-regions affecting the expression of the human CR2 gene.
    Yang LM; Behrens M; Weis JJ
    J Immunol; 1991 Oct; 147(7):2404-10. PubMed ID: 1833454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2.
    Molina H; Kinoshita T; Inoue K; Carel JC; Holers VM
    J Immunol; 1990 Nov; 145(9):2974-83. PubMed ID: 2145366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum regulates the expression of complement receptor 2 on human B cell lines.
    Tolnay M; Tsokos GC
    Immunopharmacol Immunotoxicol; 2000 May; 22(2):205-19. PubMed ID: 10952027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells.
    Chen U; Scheuermann RH; Wirth T; Gerster T; Roeder RG; Harshman K; Berger C
    Nucleic Acids Res; 1991 Nov; 19(21):5981-9. PubMed ID: 1658749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells.
    Brown SL; Barrault DV; Phythian-Adams A; Knight AM
    Int Immunol; 2006 Jan; 18(1):69-78. PubMed ID: 16291653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.